Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Gene | TP53 |
Variant | P152L |
Impact List | missense |
Protein Effect | loss of function |
Gene Variant Descriptions | TP53 P152L lies within the DNA-binding domain of the Tp53 protein (PMID: 15510160). P152L results in decreased DNA binding (PMID: 31366730), decreased Tp53 transactivation activity, inability to suppress colony formation (PMID: 25584008, PMID: 31366730), and increased cell migration in culture (PMID: 31366730). |
Associated Drug Resistance | |
Category Variants Paths |
TP53 mutant TP53 exon5 TP53 P152L TP53 mutant TP53 inact mut TP53 P152L |
Transcript | NM_000546.6 |
gDNA | chr17:g.7675157G>A |
cDNA | c.455C>T |
Protein | p.P152L |
Source Database | RefSeq |
Genome Build | GRCh38/hg38 |
Transcript | gDNA | cDNA | Protein | Source Database | Genome Build |
---|---|---|---|---|---|
NM_001126114.3 | chr17:g.7675157G>A | c.455C>T | p.P152L | RefSeq | GRCh38/hg38 |
NM_001276696 | chr17:g.7674959G>A | c.455C>T | p.P152L | RefSeq | GRCh38/hg38 |
NM_001276696.1 | chr17:g.7674959G>A | c.455C>T | p.P152L | RefSeq | GRCh38/hg38 |
NM_001276761.1 | chr17:g.7674959G>A | c.455C>T | p.P152L | RefSeq | GRCh38/hg38 |
NM_001276696.3 | chr17:g.7674959G>A | c.455C>T | p.P152L | RefSeq | GRCh38/hg38 |
NM_001407271.1 | chr17:g.7674959G>A | c.455C>T | p.P152L | RefSeq | GRCh38/hg38 |
NM_001126118.1 | chr17:g.7674959G>A | c.455C>T | p.P152L | RefSeq | GRCh38/hg38 |
NM_001407269.1 | chr17:g.7674959G>A | c.455C>T | p.P152L | RefSeq | GRCh38/hg38 |
NM_001276760.3 | chr17:g.7674959G>A | c.455C>T | p.P152L | RefSeq | GRCh38/hg38 |
NM_001126113 | chr17:g.7675157G>A | c.455C>T | p.P152L | RefSeq | GRCh38/hg38 |
NM_001276695.1 | chr17:g.7674959G>A | c.455C>T | p.P152L | RefSeq | GRCh38/hg38 |
NM_001276761 | chr17:g.7674959G>A | c.455C>T | p.P152L | RefSeq | GRCh38/hg38 |
NM_001407270.1 | chr17:g.7675157G>A | c.455C>T | p.P152L | RefSeq | GRCh38/hg38 |
NM_000546 | chr17:g.7675157G>A | c.455C>T | p.P152L | RefSeq | GRCh38/hg38 |
NM_001407265.1 | chr17:g.7674959G>A | c.455C>T | p.P152L | RefSeq | GRCh38/hg38 |
NM_001126112.3 | chr17:g.7675157G>A | c.455C>T | p.P152L | RefSeq | GRCh38/hg38 |
NM_001126113.3 | chr17:g.7675157G>A | c.455C>T | p.P152L | RefSeq | GRCh38/hg38 |
NM_001276761.3 | chr17:g.7674959G>A | c.455C>T | p.P152L | RefSeq | GRCh38/hg38 |
NM_001126113.2 | chr17:g.7675157G>A | c.455C>T | p.P152L | RefSeq | GRCh38/hg38 |
NM_001276695.3 | chr17:g.7674959G>A | c.455C>T | p.P152L | RefSeq | GRCh38/hg38 |
NM_001126118.2 | chr17:g.7674959G>A | c.455C>T | p.P152L | RefSeq | GRCh38/hg38 |
NM_001407262.1 | chr17:g.7675157G>A | c.455C>T | p.P152L | RefSeq | GRCh38/hg38 |
NM_001407264.1 | chr17:g.7675157G>A | c.455C>T | p.P152L | RefSeq | GRCh38/hg38 |
NM_001407267.1 | chr17:g.7674959G>A | c.455C>T | p.P152L | RefSeq | GRCh38/hg38 |
NM_001276760 | chr17:g.7674959G>A | c.455C>T | p.P152L | RefSeq | GRCh38/hg38 |
NM_001276760.1 | chr17:g.7674959G>A | c.455C>T | p.P152L | RefSeq | GRCh38/hg38 |
NM_001126118 | chr17:g.7674959G>A | c.455C>T | p.P152L | RefSeq | GRCh38/hg38 |
NM_001126114.2 | chr17:g.7675157G>A | c.455C>T | p.P152L | RefSeq | GRCh38/hg38 |
NM_001407263.1 | chr17:g.7674959G>A | c.455C>T | p.P152L | RefSeq | GRCh38/hg38 |
NM_001126112 | chr17:g.7675157G>A | c.455C>T | p.P152L | RefSeq | GRCh38/hg38 |
NM_001407268.1 | chr17:g.7675157G>A | c.455C>T | p.P152L | RefSeq | GRCh38/hg38 |
NM_000546.6 | chr17:g.7675157G>A | c.455C>T | p.P152L | RefSeq | GRCh38/hg38 |
NM_001407266.1 | chr17:g.7675157G>A | c.455C>T | p.P152L | RefSeq | GRCh38/hg38 |
NM_001126112.2 | chr17:g.7675157G>A | c.455C>T | p.P152L | RefSeq | GRCh38/hg38 |
NM_000546.5 | chr17:g.7675157G>A | c.455C>T | p.P152L | RefSeq | GRCh38/hg38 |
NM_001276695 | chr17:g.7674959G>A | c.455C>T | p.P152L | RefSeq | GRCh38/hg38 |
NM_001126114 | chr17:g.7675157G>A | c.455C>T | p.P152L | RefSeq | GRCh38/hg38 |
Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
---|